Cargando…

Mouse Syngeneic Melanoma Model with Human Epidermal Growth Factor Receptor Expression

The development of epidermal growth factor receptor (EGFR)-targeting agents for the treatment of malignant melanoma requires cheap and easy animal tumor models for high-throughput in vivo screening. Thus, the aim of this study was to develop mouse syngeneic melanoma model that expresses human EGFR....

Descripción completa

Detalles Bibliográficos
Autores principales:	Slastnikova, Tatiana A., Rosenkranz, Andrey A., Ulasov, Alexey V., Khramtsov, Yuri V., Lupanova, Tatiana N., Georgiev, Georgii P., Sobolev, Alexander S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9697344/ https://www.ncbi.nlm.nih.gov/pubmed/36432639 http://dx.doi.org/10.3390/pharmaceutics14112448

Ejemplares similares

An Approach to Evaluate the Effective Cytoplasmic Concentration of Bioactive Agents Interacting with a Selected Intracellular Target Protein
por: Khramtsov, Yuri V., et al.
Publicado: (2023)

Targeted Delivery of (111)In Into the Nuclei of EGFR Overexpressing Cells via Modular Nanotransporters With Anti-EGFR Affibody
por: Karyagina, Tatiana S., et al.
Publicado: (2020)

Antitumor Activity of Auger Electron Emitter (111)In Delivered by Modular Nanotransporter for Treatment of Bladder Cancer With EGFR Overexpression
por: Rosenkranz, Andrey A., et al.
Publicado: (2018)

Modular nanotransporters: a multipurpose in vivo working platform for targeted drug delivery
por: Slastnikova, Tatiana A, et al.
Publicado: (2012)

Development and evaluation of a new modular nanotransporter for drug delivery into nuclei of pathological cells expressing folate receptors
por: Slastnikova, Tatiana A, et al.
Publicado: (2017)

Among Antibody-Like Molecules, Monobodies, Able to Interact with Nucleocapsid Protein of SARS-CoV Virus, There Are Monobodies with High Affinity to Nucleocapsid Protein of SARS-CoV-2 Virus
por: Khramtsov, Y. V., et al.
Publicado: (2022)

Delivery of Antibody-Like Molecules, Monobodies, Capable of Binding with SARS-CoV-2 Virus Nucleocapsid Protein, into Target Cells
por: Khramtsov, Y. V., et al.
Publicado: (2022)

Nrf2/Keap1/ARE signaling: Towards specific regulation
por: Ulasov, Alexey V., et al.
Publicado: (2022)

Targeted Intracellular Delivery of Antibodies: The State of the Art
por: Slastnikova, Tatiana A., et al.
Publicado: (2018)

Preparation, cytotoxicity, and in vivo antitumor efficacy of (111)In-labeled modular nanotransporters
por: Slastnikova, Tatiana A, et al.
Publicado: (2017)

Modular nanotransporters: a versatile approach for enhancing nuclear delivery and cytotoxicity of Auger electron-emitting (125)I
por: Slastnikova, Tatiana A, et al.
Publicado: (2012)

Prospects of Using Protein Engineering for Selective Drug Delivery into a Specific Compartment of Target Cells
por: Rosenkranz, Andrey A., et al.
Publicado: (2023)

Properdin Is a Modulator of Tumour Immunity in a Syngeneic Mouse Melanoma Model
por: Al-Rayahi, Izzat A. M., et al.
Publicado: (2021)

Therapeutic properties of a vector carrying the HSV thymidine kinase and GM-CSF genes and delivered as a complex with a cationic copolymer
por: Alekseenko, Irina V, et al.
Publicado: (2015)

Anticancer Effect of Cold Atmospheric Plasma in Syngeneic Mouse Models of Melanoma and Colon Cancer
por: Jung, Joon-Min, et al.
Publicado: (2023)

Combination of adenoviral virotherapy and temozolomide chemotherapy eradicates malignant glioma through autophagic and apoptotic cell death in vivo
por: Ulasov, I V, et al.
Publicado: (2009)

Effect of Modified Alkaline Supplementation on Syngenic Melanoma Growth in CB57/BL Mice
por: Azzarito, Tommaso, et al.
Publicado: (2016)

Tankyrase inhibition sensitizes melanoma to PD-1 immune checkpoint blockade in syngeneic mouse models
por: Waaler, Jo, et al.
Publicado: (2020)

Searching for Promoters to Drive Stable and Long-Term Transgene Expression in Fibroblasts for Syngeneic Mouse Tumor Models
por: Antonova, Dina V., et al.
Publicado: (2020)

Epidermal Growth Factor Receptor‐mediated Selective Cytotoxicity of Antitumor Agents toward Human Xenografts and Murine Syngeneic Solid Tumors
por: Amagase, Harunobu, et al.
Publicado: (1989)

Transimmunization restores immune surveillance and prevents recurrence in a syngeneic mouse model of ovarian cancer
por: Alvero, Ayesha B., et al.
Publicado: (2020)

FTY720 inhibits mesothelioma growth in vitro and in a syngeneic mouse model
por: Szymiczek, Agata, et al.
Publicado: (2017)

Syngeneic homograft of framework regions enhances the affinity of the mouse anti-human epidermal receptor 2 single-chain antibody e23sFv
por: Ou-Yang, Qing, et al.
Publicado: (2021)

MON-311 GH Action Upregulates ABC Transporters And EMT Markers In A Syngeneic Melanoma Mouse Model
por: Qian, Yanrong, et al.
Publicado: (2019)

Injection of Syngeneic Murine Melanoma Cells to Determine Their Metastatic Potential in the Lungs
por: Timmons, Joshua J., et al.
Publicado: (2016)

THE CYTOTOXIC EFFECT OF MOUSE MACROPHAGES ON SYNGENEIC AND ALLOGENEIC ERYTHROCYTES
por: Melsom, H., et al.
Publicado: (1973)

SAT-LB054 Growth Hormone Receptor (GHR) Antagonism Suppresses Hepatocellular Carcinoma Growth in a Syngeneic Mouse Model
por: Mathes, Samuel, et al.
Publicado: (2019)

Development of a syngeneic mouse model of epithelial ovarian cancer
por: Quinn, Bridget A, et al.
Publicado: (2010)

Low-dose glucocorticoids suppresses ovarian tumor growth and metastasis in an immunocompetent syngeneic mouse model
por: Lin, Kai-Ti, et al.
Publicado: (2017)

Enhanced Growth of Syngeneic Moloney Sarcoma with Decreased Immunity in the Regressors
por: Mayer, A. M. S., et al.
Publicado: (1977)

Promotion of fibrosarcoma cell growth by products of syngeneic host macrophages.
por: Currie, G. A.
Publicado: (1981)

Editorial: Delivery of Locally-Acting Agents to Intracellular Targets
por: Rosenkranz, Andrey A., et al.
Publicado: (2020)

Radiation Responses of Subrenally Transplanted Syngeneic and Allogeneic Mouse Fibrosarcomas
por: Sato, Setsu, et al.
Publicado: (1988)

Single-Cell Landscape of Mouse Islet Allograft and Syngeneic Graft
por: Chen, Pengfei, et al.
Publicado: (2022)

Enhanced Anticancer Effect of a Combination of S-adenosylmethionine (SAM) and Immune Checkpoint Inhibitor (ICPi) in a Syngeneic Mouse Model of Advanced Melanoma
por: Mehdi, Ali, et al.
Publicado: (2020)

Growth of Syngeneic Tumours in Unimmunized Newborn and Adult Hosts
por: Forni, G., et al.
Publicado: (1973)

Reverse Translating Molecular Determinants of Anti–Programmed Death 1 Immunotherapy Response in Mouse Syngeneic Tumor Models
por: Georgiev, Peter, et al.
Publicado: (2022)

Current Approaches for Improving Intratumoral Accumulation and Distribution of Nanomedicines
por: Durymanov, Mikhail O, et al.
Publicado: (2015)

Diverse roles of epidermal growth factors receptors in oral and cutaneous canine melanomas
por: Veloso, Emerson Soares, et al.
Publicado: (2020)

Single CAR-T cell treatment controls disseminated ovarian cancer in a syngeneic mouse model
por: Ranoa, Diana Rose E, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_5pfa8s4hhulg5hlo87age4rfog